Shyam S. Bhartia
-
Jubilant Pharmova registers consolidated PAT of Rs 213.90 crore in Q4FY21
Reports a total income of Rs 1586.47 crores The Board of Jubilant Pharmova has approved the financial results for the…
Read More » -
Jubilant Life Sciences Announces Launch of ‘JUBI-R’ for Treatment of COVID-19
India : Jubilant Life Sciences Limited, an integrated global pharmaceutical and life sciences company has announce that its subsidiary, Jubilant Generics…
Read More »
